Praxis Precision Medicines, Inc. PRAX Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s change in accrued liabilities?
- Praxis Precision Medicines, Inc. (PRAX) reported change in accrued liabilities of -$17.39M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s change in accrued liabilities changed year-over-year?
- Praxis Precision Medicines, Inc.'s change in accrued liabilities decreased by 110.0% year-over-year, from -$8.28M to -$17.39M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s change in accrued liabilities?
- Over 2 years (2021 to 2024), Praxis Precision Medicines, Inc.'s change in accrued liabilities has grown at a 2.1% compound annual growth rate (CAGR), from $15.45M to $16.11M.